Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction

BACKGROUNDS: Fimasartan is the most recently developed, potent, and long-acting angiotensin II receptor blocker (ARB). However, data are limited regarding treatment effects of fimasartan in patients with heart failure. METHODS: Between 2010 and 2016, patients who underwent coronary revascularization...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jihoon, Kang, Danbee, Kim, Sung Eun, Park, Hyejeong, Park, Taek Kyu, Lee, Joo Myung, Yang, Jeong Hoon, Song, Young Bin, Choi, Jin-Ho, Choi, Seung-Hyuk, Gwon, Hyeon-Cheol, Guallar, Eliseo, Cho, Juhee, Hahn, Joo-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293657/
https://www.ncbi.nlm.nih.gov/pubmed/37365730
http://dx.doi.org/10.3346/jkms.2023.38.e202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293657/
https://www.ncbi.nlm.nih.gov/pubmed/37365730
http://dx.doi.org/10.3346/jkms.2023.38.e202

Ejemplares similares